IMARC Group, a leading market research company, has recently releases report titled “Joint Reconstruction Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028. The report offers a comprehensive analysis of the industry, which comprises insights on the global joint reconstruction devices market report. The global joint reconstruction devices market size reached US$ 26.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 36.5 Billion by 2028, exhibiting a growth rate (CAGR) of 5.3% during 2023-2028.
Joint reconstruction devices are medical implants used to restore the normal function and structure of damaged or arthritic joints in the human body. They are designed to be durable, providing a long-lasting solution to joint problems, which minimizes the need for frequent revisions or replacements. They play a crucial role in improving the quality of life of individuals suffering from joint-related issues. They help alleviate chronic pain and discomfort associated with conditions like osteoarthritis and joint injuries. They enable patients to regain their ability to move freely and perform daily activities with ease. They can also restore the function of joints, allowing individuals to recover strength and stability in their affected joint. As they allow people to participate in physical activities, enjoy hobbies, and engage in social interactions more comfortably, the demand for joint reconstruction devices is increasing worldwide.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/joint-reconstruction-devices-market/requestsample
Joint Reconstruction Devices Market Trends and Drivers:
At present, the rising prevalence of age-related joint issues, such as osteoarthritis, among the geriatric population represents one of the key factors supporting the growth of the market. Besides this, the increasing occurrence of obesity worldwide is contributing to the growing demand for joint reconstruction surgeries and devices. Moreover, innovations in materials, implant designs, and surgical techniques are leading to the development of enhanced joint reconstruction devices. These advancements result in better outcomes, shorter recovery times, and increased patient satisfaction. In addition, the growing participation among younger individuals in sports is leading to the rising number of sports-related injuries, which is positively influencing the market. Apart from this, patients are becoming more informed about joint issues and treatment options through online resources and healthcare providers. This, in turn, is offering lucrative growth opportunities to industry investors. Additionally, advancements in minimally invasive (MI) surgical techniques are leading to reduce recovery times and minimize complications, making joint reconstruction surgeries more appealing to patients around the world.
Competitive Landscape with Key Player:
- Aesculap Inc. (B. Braun Melsungen AG)
- Conformis Inc.
- Conmed Corporation
- DJO Global Inc. (Enovis Corporation)
- Exactech Inc.
- Johnson & Johnson Services Inc
- Kyocera Medical Technologies Inc. (Kyocera Corporation)
- Medacta International SA
- Smith & Nephew plc
- Stryker Corporation
- Zimmer Biomet.
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Technique:
- Joint Replacement
- Implants
- Bone Graft
- Osteotomy
- Arthroscopy
- Resurfacing
- Arthrodesis
- Others
Breakup by Joint Type:
- Knee
- Hip
- Shoulder
- Ankle
- Others
Breakup by End User:
- Hospitals
- Orthopedic Clinics
- Ambulatory Surgical Centers (ASCs)
- Others
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800\
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Follow us on Twitter: @imarcglobal
